C‐Met in invasive breast cancer

E-ISSN： 1097-0142|120|2|163-171

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.2, 2014-01, pp. : 163-171

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

c-Met Expression in Gastric Cancer with Liver Metastasis

Oncology, Vol. 63, Iss. 3, 2002-10 ,pp. : 286-296

Karger

Access to resources Recommend Favorite

Clinical Significance of c-met Oncogene Alterations in Human Colorectal Cancer

Oncology, Vol. 56, Iss. 4, 1999-05 ,pp. : 314-321

Karger

Access to resources Recommend Favorite

Potent antitumor activity of cabozantinib, a c‐MET and VEGFR2 inhibitor, in a colorectal cancer patient‐derived tumor explant model

INTERNATIONAL JOURNAL OF CANCER, Vol. 136, Iss. 8, 2015-04 ,pp. : 1967-1975

John Wiley & Sons Inc

Access to resources Recommend Favorite

Targeting c‐Met in Cancer by MicroRNAs: Potential Therapeutic Applications in Hepatocellular Carcinoma

DRUG DEVELOPMENT RESEARCH, Vol. 76, Iss. 7, 2015-11 ,pp. : 357-367

John Wiley & Sons Inc

Access to resources Recommend Favorite

Review of Clinic Trials: Agents Targeting c-Met

Reviews on Recent Clinical Trials, Vol. 2, Iss. 2, 2007-05 ,pp. : 143-147

Bentham Science Publishers

Access to resources Recommend Favorite